Letter to the Editor tromagnetics 2003;24:[removed].

First Page		Document Content
Vitiligo Melanocyte Dermatology Keratinocyte Hair follicle Pimecrolimus Corneocyte Biology Anatomy Medicine		Letter to the Editor tromagnetics 2003;24:[removed]. Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 3,19 MB Share Document on Facebook

	MEDA Pharmaceuticals Pty Ltd Elidel® Cream Pimecrolimus 1 % w/w Consumer Medicine Information DocID: 1mrCV - View Document
	New Zealand Datasheet Name of Medicine ELIDEL® Pimecrolimus 1% Cream Presentation DocID: 1mrsD - View Document
	PDF Document DocID: 17f7c - View Document
	Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, book 1 TREATMENT OF PSORIASIS VULGARIS WITH ELIDEL S. Racheva, R. Bachvarova, J. Dimitrova Department and clinic of dermatovenerology DocID: 12xu8 - View Document
	TOPICAL IMMUNOMODULATOR CRITERIA Pharmacology: Pimecrolimus inhibits the calcium-dependent phosphatase (calcineurin), interfering with T-cell activation and transcription of early cytokines. Thus, it decreases the synthe DocID: MiMH - View Document